{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:20:09Z","timestamp":1784280009728,"version":"3.55.0"},"reference-count":27,"publisher":"American Psychiatric Association Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1176\/appi.ajp.159.3.460","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:20:39Z","timestamp":1034360439000},"page":"460-465","source":"Crossref","is-referenced-by-count":242,"title":["Comparison of Citalopram, Perphenazine, and Placebo for the Acute Treatment of Psychosis and Behavioral Disturbances in Hospitalized, Demented Patients"],"prefix":"10.1176","volume":"159","author":[{"given":"Bruce G.","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sati","family":"Mazumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Bharucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. J.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari B.","family":"Kastango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marci L.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1593CHDCECFH","doi-asserted-by":"crossref","unstructured":"Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV: Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 2000; 54:1965-1971","DOI":"10.1212\/WNL.54.10.1965"},{"key":"R1593CHDHCFIA","doi-asserted-by":"crossref","unstructured":"Schulz R, O\u2019Brien AT, Bookwala J, Fleissner K: Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. Gerontologist 1995; 35:771-791","DOI":"10.1093\/geront\/35.6.771"},{"key":"R1593CHDDJHDG","doi-asserted-by":"crossref","unstructured":"Pollock BG, Mulsant BH: Behavioral disturbances of dementia. J Geriatr Psychiatry Neurol 1998; 11:206-212","DOI":"10.1177\/089198879901100407"},{"key":"R1593CHDHAIAF","unstructured":"Pollock BG, Rosen J, Mulsant BH: Antipsychotics and selective serotonin reuptake inhibitors for the treatment of behavioral disturbances in dementia of the Alzheimer type: a review of clinical data. Consultant Pharmacist 1999; 11:1251-1258"},{"key":"R1593CHDHHIHC","doi-asserted-by":"crossref","unstructured":"Schneider LS, Pollock VE, Lyness SA: A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563","DOI":"10.1111\/j.1532-5415.1990.tb02407.x"},{"key":"R1593CHDCCACI","doi-asserted-by":"crossref","unstructured":"Pollock BG, Mulsant BH: Antipsychotics in older patients: a safety perspective. Drugs Aging 1995; 6:312-323","DOI":"10.2165\/00002512-199506040-00006"},{"key":"R1593CHDCDIGF","unstructured":"Pollock BG, Mulsant BH, Sweet RA, Rosen J, Altieri LP, Peril J: Prospective cytochrome P450 2D6 phenotyping for neuroleptic treatment in dementia. Psychopharmacol Bull 1995; 31:327-331"},{"key":"R1593CHDJEAEJ","doi-asserted-by":"crossref","unstructured":"Lawlor BA: Serotonin and Alzheimer\u2019s disease. Psychiatr Annals 1990; 20:567-569","DOI":"10.3928\/0048-5713-19901001-07"},{"key":"R1593CHDGAADA","doi-asserted-by":"crossref","unstructured":"Sultzer DL, Gray KF, Gunay I, Berisford MA, Mahler ME: A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997; 5:60-69","DOI":"10.1097\/00019442-199705010-00008"},{"key":"R1593CHDIFIJA","doi-asserted-by":"crossref","unstructured":"Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ: Treatment of agitation in AD: a randomized, placebo-controlled clinical trial: Alzheimer\u2019s Disease Cooperative Study. Neurology 2000; 55:1271-1278; correction, 2001; 56:426","DOI":"10.1212\/WNL.55.9.1271"},{"key":"R1593CHDDEJEJ","doi-asserted-by":"crossref","unstructured":"Dehlin O, Hedenrud B, Jansson P, Norgard JA: A double-blind comparison of alaproclate and placebo in the treatment of patients with senile dementia. Acta Psychiatr Scand 1985; 71:190-196","DOI":"10.1111\/j.1600-0447.1985.tb01270.x"},{"key":"R1593CHDGDAAC","doi-asserted-by":"crossref","unstructured":"Olafsson K, Jorgensen S, Jensen HV, Bille A, Arup P, Anderson J: Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. Acta Psychiatr Scand 1992; 85:453-456","DOI":"10.1111\/j.1600-0447.1992.tb03211.x"},{"key":"R1593CHDHJAHI","doi-asserted-by":"crossref","unstructured":"Nyth AL, Gottfries CG: The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990; 157:894-901","DOI":"10.1192\/bjp.157.6.894"},{"key":"R1593CHDIBFEE","doi-asserted-by":"crossref","unstructured":"Pollock BG, Mulsant BH, Sweet R, Burgio LD, Kirshner MA, Shuster K, Rosen J: An open pilot study of citalopram for behavioral disturbances of dementia. Am J Geriatr Psychiatry 1997; 5:70-78","DOI":"10.1097\/00019442-199705010-00009"},{"key":"R1593CHDBEEIA","doi-asserted-by":"crossref","unstructured":"Levin HS, High WM, Goethe KE, Sisson RA, Overall JE, Rhoades HM, Eisenberg HM, Kalisky Z, Gary HE: The Neurobehavioral Rating Scale: assessment of the behavioural sequelae of head injury by the clinician. J Neurol Neurosurg Psychiatry 1987; 50:183-193","DOI":"10.1136\/jnnp.50.2.183"},{"key":"R1593CHDEBGDB","doi-asserted-by":"crossref","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334:1-100","DOI":"10.1111\/j.1600-0447.1987.tb10566.x"},{"key":"R1593CHDJHHEA","doi-asserted-by":"crossref","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"R1593CHDGJCGB","doi-asserted-by":"crossref","unstructured":"Mulsant BH, Mazumdar S, Pollock BG, Sweet RA, Rosen J, Lo K: Methodological issues in characterizing treatment response in demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1997; 12:537-547","DOI":"10.1002\/(SICI)1099-1166(199705)12:5<537::AID-GPS542>3.3.CO;2-Q"},{"key":"R1593CHDEJGJF","doi-asserted-by":"crossref","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 1984; 34:939-944","DOI":"10.1212\/WNL.34.7.939"},{"key":"R1593CHDCJAHD","doi-asserted-by":"crossref","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry ED, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996; 47:1113-1124","DOI":"10.1212\/WNL.47.5.1113"},{"key":"R1593CHDJGABC","doi-asserted-by":"crossref","unstructured":"Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M (Risperidone Study Group): Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999; 60:107-115","DOI":"10.4088\/JCP.v60n0207"},{"key":"R1593CHDEICGF","doi-asserted-by":"crossref","unstructured":"Jeste DV, Finkel SI: Psychosis of Alzheimer\u2019s disease and related dementias. Am J Geriatr Psychiatry 2000; 8:29-34","DOI":"10.1097\/00019442-200002000-00004"},{"key":"R1593CHDCEAEF","doi-asserted-by":"crossref","unstructured":"Ballard CG, Bannister CL, Patel A, Graham C, Oyebode F, Wilcock G, Chung MC: Classification of psychotic symptoms in dementia sufferers. Acta Psychiatr Scand 1995; 92:63-68","DOI":"10.1111\/j.1600-0447.1995.tb09544.x"},{"key":"R1593CHDGFBAI","doi-asserted-by":"crossref","unstructured":"Tsai S-J, Hwang J-P, Yang C-H, Liu K-M: Delusional jealousy in dementia. J Clin Psychiatry 1997; 58:492-494","DOI":"10.4088\/JCP.v58n1105"},{"key":"R1593CHDDBAIC","doi-asserted-by":"crossref","unstructured":"Pies R: Must we now consider SRIs neuroleptics? (editorial). J Clin Psychopharmacol 1997; 17:443-445","DOI":"10.1097\/00004714-199712000-00001"},{"key":"R1593CHDIIEAB","doi-asserted-by":"crossref","unstructured":"Holmes C, Arranz MJ, Powell JF, Collier DA, Lovestone S: 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer\u2019s disease. Hum Mol Genet 1998; 7:1507-1509","DOI":"10.1093\/hmg\/7.9.1507"},{"key":"R1593CHDBDBID","doi-asserted-by":"crossref","unstructured":"Sukonick DL, Pollock BG, Sweet RA, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE: The 5-HTTPR*S\/*L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol 2001; 58:1425-1428","DOI":"10.1001\/archneur.58.9.1425"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.3.460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T10:15:42Z","timestamp":1722420942000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.3.460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["10.1176\/appi.ajp.159.3.460"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.3.460","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}